|
Lucy Scientific Discovery Inc (NASDAQ: LSDI) |
|
Lucy Scientific Discovery Inc
LSDI's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Lucy Scientific Discovery Inc growth rates, revenue grew
in II. Quarter 2023 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
deterioration of revenues by -4.85 %
Lucy Scientific Discovery Inc net loss increased from $-1 millions, to $-3 millions in II. Quarter 2023,
• More on LSDI's Growth
|
|
Lucy Scientific Discovery Inc realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 49 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 936.43.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.28.
• More on LSDI's Valuation
|
|
|
|
|
Lucy Scientific Discovery Inc realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 49 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 936.43.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.28.
Lucy Scientific Discovery Inc Price to Book Ratio is at 111.74 higher than Industry Avg. of 90.11, and higher than S&P 500 Avg. of 0.01
• More on LSDI's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com